Literature DB >> 15907259

Nonpharmacologic treatment of migraine.

Peter S Sándor1, Judit Afra.   

Abstract

Nonpharmacologic treatment of migraine is often used by patients and can provide interesting options for physicians. Knowledge about the evidence and its absence is important. Avoidance of trigger factors can help, if individualized. Behavioral approaches, such as relaxation techniques, biofeedback, and cognitive-behavioral therapy, require far more specialist time or technical devices, but are supported by some evidence, which is mostly old. The same is true for hypnosis. A new approach in migraine prevention is aerobic exercise, which is associated with positive side effects. Whether it will take a strong role, similar to the treatment of depression, remains to be seen. There is no convincing evidence for the efficacy of spinal manipulation. Hyperbaric oxygen may be an effective, but rarely practical prophylactic measure. The evidence pertaining to the efficacy of acupuncture is controversial because of methodologic difficulties, but an ongoing large German study may provide valuable evidence in the near future. Nutritional supplements acting on mitochondrial metabolism, such as magnesium, riboflavin, and coenzyme Q10, were shown to be effective in small, randomized, controlled trials. More studies on the different therapeutic interventions are needed, using modern diagnostic standards and state-of-the-art trial methodology.

Entities:  

Mesh:

Year:  2005        PMID: 15907259     DOI: 10.1007/s11916-005-0063-y

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  29 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Migraine and hypnotherapy.

Authors:  J A Anderson; M A Basker; R Dalton
Journal:  Int J Clin Exp Hypn       Date:  1975-01

3.  Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

Authors:  J Schoenen; J Jacquy; M Lenaerts
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

4.  Mechanism of the biofeedback therapy of migraine: volitional manipulation of the psychophysiological background.

Authors:  M Sovak; M Kunzel; R A Sternbach; D J Dalessio
Journal:  Headache       Date:  1981-05       Impact factor: 5.887

Review 5.  Menstruation, sex hormones, and migraine.

Authors:  E A MacGregor
Journal:  Neurol Clin       Date:  1997-02       Impact factor: 3.806

6.  Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study.

Authors:  P-H M van der Kuy; F W H M Merkus; J J H M Lohman; J W M ter Berg; P M Hooymans
Journal:  Cephalalgia       Date:  2002-09       Impact factor: 6.292

7.  Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride.

Authors:  K A Holroyd; J L France; G E Cordingley; L A Rokicki; S A Kvaal; G L Lipchik; H R McCool
Journal:  J Consult Clin Psychol       Date:  1995-04

8.  Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle.

Authors:  Birthe Krogh Rasmussen
Journal:  Pain       Date:  1993-04       Impact factor: 6.961

9.  A preliminary report on hyperbaric oxygen in the relief of migraine headache.

Authors:  D E Myers; R A Myers
Journal:  Headache       Date:  1995-04       Impact factor: 5.887

10.  Biofeedback control of migraine headaches: a comparison of two approaches.

Authors:  J Gauthier; R Lacroix; A Coté; J Doyon; M Drolet
Journal:  Biofeedback Self Regul       Date:  1985-06
View more
  3 in total

Review 1.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

3.  Italian guidelines for primary headaches: 2012 revised version.

Authors:  Paola Sarchielli; Franco Granella; Maria Pia Prudenzano; Luigi Alberto Pini; Vincenzo Guidetti; Giorgio Bono; Lorenzo Pinessi; Massimo Alessandri; Fabio Antonaci; Marcello Fanciullacci; Anna Ferrari; Mario Guazzelli; Giuseppe Nappi; Grazia Sances; Giorgio Sandrini; Lidia Savi; Cristina Tassorelli; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2012-05       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.